fda-catalyst-vaccines
FeaturedVaccine catalyst analysis across the two-gate path: CBER BLA review and the ACIP recommendation gate that turns FDA approval into commercial availability. Lot release, procurement milestones, pediatric bridging, and healthy-population efficacy context — dated, verified, and sized per event.
Install
Quality Score: 94/100
Skill Content
Details
- Author
- agentii-ai
- Repository
- agentii-ai/agentii-investment-intelligence
- Created
- 4 months ago
- Last Updated
- 2 days ago
- Language
- Python
- License
- Apache-2.0
Similar Skills
Semantically similar based on skill content — not just same category
fda-catalyst-analysis
Dated FDA catalyst calendar (PDUFA target dates, AdCom meetings, device decisions, trial readouts, earnings) with AdCom-style scrutiny outcome framing and historical-case grounding. The FDA decision is the strongest stock catalyst in med.medicines_biotech — use this skill to enumerate, verify, and size upcoming catalysts for any biotech/pharma ticker or watchlist.
fda-catalyst-medicines
CDER-track catalyst analysis for medicines: PDUFA target dates, AdCom votes, sNDA/sBLA label expansions, biosimilar interchangeability and 180-day exclusivity, Orange Book state, and CRL remediation timelines — enumerated, verified, and sized per event for any biotech/pharma ticker or watchlist.
pipeline-vaccines
Vaccine pipeline analysis: immunogenicity and seroconversion studies, lot-consistency trials, healthy-population efficacy designs, and age-cohort bridging, with the ACIP gate built into the value path across the med universe.